Loss of asthma control after cessation of omalizumab treatment: real life data.
about
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potentialGuidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendationsEfficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort studyChildren with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland.Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience.Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia.Omalizumab in an allergology clinic: real life experience and future developments.Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody.Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report.Biologic agents for severe asthma patients: clinical perspectives and implications.A step-down protocol for omalizumab treatment in oral corticosteroid-dependent allergic asthma patients.Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study.
P2860
Q28080207-8A4B3DDA-5A1C-4C3D-834A-D89BA0F8F8B4Q28392274-41474362-CCC8-48DF-880D-D6E6224359E7Q35889211-B5CA018C-9E50-4294-9DA6-B361FF6640D4Q35992096-A286D1A2-D525-46EA-BED4-8CE84DE72952Q36000022-8D55DE83-AAC9-4F64-BFCE-441E47B17221Q36418905-4E80857E-4858-4473-A72E-8E4AE629A27DQ37634329-2063442A-4EB5-478C-B56F-C132A935C576Q38790815-EBC8F977-9140-4FC3-8F8B-7EAB466527C1Q38811111-7BEAFA13-932E-4F67-A26A-4E53FDBA6EC7Q39148249-DFCEB996-2F99-435E-A941-1CC63E81EF5DQ47576873-5892567D-BE9A-4647-87E5-DF0C1F016895Q48169301-D5ADDE16-E76B-4A59-BE4F-1CCB2CD3A337Q51744142-6AE594BC-4160-4B2D-A67C-AB7DC5314985
P2860
Loss of asthma control after cessation of omalizumab treatment: real life data.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Loss of asthma control after cessation of omalizumab treatment: real life data.
@ast
Loss of asthma control after cessation of omalizumab treatment: real life data.
@en
type
label
Loss of asthma control after cessation of omalizumab treatment: real life data.
@ast
Loss of asthma control after cessation of omalizumab treatment: real life data.
@en
prefLabel
Loss of asthma control after cessation of omalizumab treatment: real life data.
@ast
Loss of asthma control after cessation of omalizumab treatment: real life data.
@en
P2860
P356
P1476
Loss of asthma control after cessation of omalizumab treatment: real life data.
@en
P2093
Izabela Kupryś-Lipińska
Piotr Kuna
P2860
P356
10.5114/PDIA.2014.40553
P577
2014-02-25T00:00:00Z